APOTEX Corp. has launched imatinib mesylate tablets, the generic equivalent of Gleevec by Novartis. Apotex’s Imatinib Mesylate Tablets are now available in 100mg and 400mg strengths. According to IMS Health, Gleevec had approximately $2.4 billion in sales in the 12 months ending in May 2016. jQuery(document).ready(function(){ jQuery('.people-thumb + p > span.has-red-100-color, .people-thumb + p >...
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
